Hologic, Inc. (HOLX) Reports In-Line Q2 EPS; Guides Q4 Revs
Tweet
Share
E-mailGet Alerts HOLX Hot Sheet
Price: $76.01 --0%
Financial Fact:
Cost of product sales - amortization of intangible assets: 71.3M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Cost of product sales - amortization of intangible assets: 71.3M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Hologic, Inc. (NASDAQ: HOLX) reported Q2 EPS of $0.32, in-line with the analyst estimate of $0.32. Revenue for the quarter came in at $451.1 million versus the consensus estimate of $447 million.
Sees Q4 2011 revenue of $455-$460 million, versus the consensus of $454 million.
Sees Q4 2011 revenue of $455-$460 million, versus the consensus of $454 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
